Dewpoint Therapeutics
Nino Jeena, MBA, is an experienced finance professional currently serving as the Senior Director and Head of Financial Planning & Analysis (FP&A) at Dewpoint Therapeutics since August 2021. Previous roles include Associate Director of FP&A at Dewpoint, Senior Manager of Corporate FP&A at Fulcrum Therapeutics, Manager of Corporate and Commercial FP&A at T2 Biosystems, and Financial Planning and Analysis Manager at Steward Health Care. Nino has a robust background in budget management, financial modeling, and collaboration with cross-functional teams. Educational qualifications include an MBA from Babson F.W. Olin Graduate School of Business and a B.B.A. in Finance & Accounting from Hofstra University.
This person is not in the org chart
Dewpoint Therapeutics
Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions has pathways that are regulated by condensates or arise from the dysfunction of condensates - including cancer, neurodegeneration, and metabolic disease.